We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SLN market cap is 771.33M. The company's latest EPS is GBP -1.1774 and P/E is -5.99.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 3.64M | 3.37M | 4.77M | 11.37M | 9.1M |
| Operating Income | -14.21M | -13.62M | -10.96M | -12.07M | -11.15M |
| Net Income | -11.94M | -7.1M | -13.76M | -10.2M | -10.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 244k | 5.48M | 12.42M | 17.5M | 25.38M |
| Operating Income | -22.73M | -32.48M | -45.81M | -48.59M | -49.6M |
| Net Income | -19.58M | -32.55M | -39.41M | -40.49M | -43.27M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 83.4M | 124.04M | 107.5M | 94.34M | 92.71M |
| Total Liabilities | 88.14M | 89.91M | 85.43M | 77.75M | 80.46M |
| Total Equity | -4.74M | 34.13M | 22.07M | 16.59M | 12.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 46.08M | 85.97M | 96.19M | 107.5M | 93.82M |
| Total Liabilities | 25.17M | 76.91M | 87.67M | 85.43M | 76.77M |
| Total Equity | 20.91M | 9.06M | 8.53M | 22.07M | 17.05M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -22.64M | N/A | -45.46M | -7.66M | -22.61M |
| Investing | -86k | N/A | -16.54M | 128k | -4.58M |
| Financing | -58k | N/A | 43.05M | 19k | 3.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 1.73M | -10.78M | 6.81M | -45.46M | -39.35M |
| Investing | -15.02M | 9.62M | 8.68M | -16.54M | 16.43M |
| Financing | 5.27M | 15.43M | 30.71M | 43.05M | 25.16M |
| Market Cap | 771.33M |
| Price to Earnings Ratio | -5.99 |
| Price to Sales Ratio | 10.21 |
| Price to Cash Ratio | 4.79 |
| Price to Book Ratio | 15.19 |
| Dividend Yield | - |
| Shares Outstanding | 36.75M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.79 (7.85%) |
| Company Name | Silence Therapeutics PLC |
| Address |
27 eastcastle street london W1W 8DH |
| Website | https://www.silence-therapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
